This suggests that a small subset of peripheral blood T cells can migrate into tumor sites, retaining stem-like properties and anti-tumor functionality, while further upregulating CD103 expression within the TME to differentiate into CD103P cells with elevated exhaustion markers and enhanced anti-tumor capacity. Here, ITGAE is linked to neoplasm.